Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program.
Cancers (Basel)
; 14(3)2022 Jan 28.
Article
de En
| MEDLINE
| ID: mdl-35158928
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Aspects:
Patient_preference
Langue:
En
Journal:
Cancers (Basel)
Année:
2022
Type de document:
Article
Pays d'affiliation:
France
Pays de publication:
Suisse